Stemtech Corporation (STEK)
OTCMKTS
· Delayed Price · Currency is USD
0.0218
-0.0027 (-11.02%)
Apr 28, 2025, 3:52 PM EDT
Stemtech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 5.1 | 4.92 | 4.56 | 4.32 | 4.38 | 6.62 |
| Revenue Growth (YoY) | 9.96% | 7.94% | 5.51% | -1.44% | -33.75% | - |
| Cost of Revenue | 1.28 | 1 | 1.16 | 1.02 | 0.72 | 1.23 |
| Gross Profit | 3.82 | 3.92 | 3.4 | 3.3 | 3.67 | 5.39 |
| Selling, General & Admin | 7.67 | 8.13 | 8.42 | 6.51 | 5.1 | 8.03 |
| Research & Development | - | 0.01 | - | - | 0 | 0 |
| Operating Expenses | 7.67 | 8.14 | 8.42 | 6.51 | 5.1 | 8.03 |
| Operating Income | -3.85 | -4.22 | -5.02 | -3.21 | -1.43 | -2.64 |
| Interest Expense | -1.61 | -4.89 | -4.1 | -8.33 | -0.16 | -0.03 |
| Other Non Operating Income (Expenses) | -0.09 | 1.51 | -3.22 | 4.43 | -0.03 | -0.08 |
| EBT Excluding Unusual Items | -5.55 | -7.61 | -12.34 | -7.11 | -1.62 | -2.75 |
| Gain (Loss) on Sale of Assets | - | - | - | - | -0.11 | -0.09 |
| Other Unusual Items | 0.31 | 2.18 | 3.8 | - | - | - |
| Pretax Income | -5.24 | -5.43 | -8.54 | -7.11 | -1.73 | -2.84 |
| Income Tax Expense | - | - | 0.1 | - | -0 | 0.03 |
| Earnings From Continuing Operations | -5.24 | -5.43 | -8.63 | -7.11 | -1.73 | -2.87 |
| Minority Interest in Earnings | 0 | 0 | 0.09 | 0.03 | 0.81 | 0.08 |
| Net Income | -5.24 | -5.43 | -8.54 | -7.08 | -0.92 | -2.79 |
| Net Income to Common | -5.24 | -5.43 | -8.54 | -7.08 | -0.92 | -2.79 |
| Shares Outstanding (Basic) | 112 | 83 | 46 | 35 | 9 | 5 |
| Shares Outstanding (Diluted) | 112 | 83 | 46 | 35 | 9 | 5 |
| Shares Change (YoY) | 61.66% | 81.40% | 30.31% | 279.07% | 73.44% | - |
| EPS (Basic) | -0.05 | -0.07 | -0.19 | -0.20 | -0.10 | -0.52 |
| EPS (Diluted) | -0.05 | -0.07 | -0.19 | -0.20 | -0.10 | -0.52 |
| Free Cash Flow | -0.71 | -2.04 | -1.22 | -1.91 | -0.28 | -1.01 |
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.03 | -0.05 | -0.03 | -0.19 |
| Gross Margin | 74.96% | 79.65% | 74.47% | 76.32% | 83.69% | 81.47% |
| Operating Margin | -75.40% | -85.84% | -110.18% | -74.29% | -32.66% | -39.82% |
| Profit Margin | -102.67% | -110.34% | -187.41% | -163.78% | -20.91% | -42.18% |
| Free Cash Flow Margin | -13.98% | -41.37% | -26.69% | -44.30% | -6.35% | -15.29% |
| EBITDA | -3.35 | -3.64 | -3.12 | -2.78 | -1 | -2.18 |
| EBITDA Margin | -65.59% | -73.89% | -68.40% | -64.37% | -22.84% | -32.97% |
| D&A For EBITDA | 0.5 | 0.59 | 1.9 | 0.43 | 0.43 | 0.45 |
| EBIT | -3.85 | -4.22 | -5.02 | -3.21 | -1.43 | -2.64 |
| EBIT Margin | -75.40% | -85.84% | -110.18% | -74.29% | -32.66% | -39.82% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.